fda approved glp-1 drugs Market Overview: Agonists and the Obesity Market | Blog GLP-1 Costs Explained: Managing Coverage

In 2024, we also saw unprecedented willingness by large numbers of patients to pay out of pocket, even in European markets, as public coverage of AOMs is still limited, at best, and more often non-existent

Codeage GLP-1 Probiotic+ is manufactured in the USA with global ingredients in a cGMP-certified facility

Not for human or veterinary use

A variety of fixed combinations of 2 agents are available in the US and in many other countries

The product also includes BCAAs, which not only support muscle endurance but also contribute to a healthier gut environment by supporting digestive health

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), initially developed for glycaemic control in patients with type 2 diabetes, have demonstrated significant cardiometabolic benefits